4//SEC Filing
O'Byrne Jason 4
Accession 0001628280-24-006433
CIK 0001619856other
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 5:28 PM ET
Size
7.5 KB
Accession
0001628280-24-006433
Insider Transaction Report
Form 4
O'Byrne Jason
Chief Financial Officer
Transactions
- Award
Common Stock
2024-02-20+33,000→ 59,224 total - Award
Option to purchase Common Stock
2024-02-20+153,000→ 153,000 totalExercise: $6.81Exp: 2034-02-19→ Common Stock (153,000 underlying)
Footnotes (3)
- [F1]This reflects restricted stock units ("RSUs") that vest in four equal annual installments beginning on February 20, 2025, subject to the reporting person's continued services to the Issuer through the applicable vesting dates. The RSUs will be settled in stock within 30 days after each vesting date.
- [F2]Includes 1,888 shares purchased pursuant to the Issuer's 2021 Employee Stock Purchase Plan on February 15, 2022 for $9.85 per share.
- [F3]25% of the options will vest upon the one-year anniversary of the grant date, February 20, 2025, and 1/48th will vest monthly thereafter over the 36-month period following the one-year cliff, subject to the reporting person's continued service to the Issuer through the applicable vesting dates.
Documents
Issuer
Caribou Biosciences, Inc.
CIK 0001619856
Entity typeother
Related Parties
1- filerCIK 0001871145
Filing Metadata
- Form type
- 4
- Filed
- Feb 21, 7:00 PM ET
- Accepted
- Feb 22, 5:28 PM ET
- Size
- 7.5 KB